Hedeker Wealth, LLC Gilead Sciences, Inc. Transaction History

Hedeker Wealth, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$57.72 - $65.01 $1.13 Million - $1.27 Million	-19,605 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$57.92 - $72.58 $273,556 - $342,795	4,723 Added 31.74%	19,605 $1.17 Million
Q4 2021 Feb 01, 2022	SELL	$64.88 - $73.64 $13,430 - $15,243	-207 Reduced 1.37%	14,882 $1.08 Million
Q3 2021 Oct 27, 2021	BUY	$67.69 - $73.03 $107,220 - $115,679	1,584 Added 11.73%	15,089 $1.05 Million
Q2 2021 Jul 21, 2021	SELL	$63.47 - $69.35 $32,813 - $35,853	-517 Reduced 3.69%	13,505 $929,000
Q1 2021 May 04, 2021	SELL	$60.0 - $68.46 $6,660 - $7,599	-111 Reduced 0.79%	14,022 $906,000
Q4 2020 Jan 19, 2021	BUY	$56.65 - $64.55 $163,548 - $186,355	2,887 Added 25.67%	14,133 $823,000
Q3 2020 Oct 26, 2020	SELL	$62.1 - $78.08 $38,998 - $49,034	-628 Reduced 5.29%	11,246 $710,000
Q2 2020 Aug 13, 2020	BUY	$72.34 - $84.0 $858,965 - $997,416	11,874 New	11,874 $913,000

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Hedeker Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Hedeker Wealth, LLC with notifications on news.